|Name||Benylin Dry Cough|
Benylin Dry Cough is used to treat or relieve symptoms of the following diseases: Coughing,
Dextromethorphan is used to treat a cough. It is available over-the-counter alone and is also present in many over-the-counter and prescription combination medications.
Benylin Dry Cough is a drug made in South Africa, United Kingdom. You need a doctor's prescription to buy it. But its analogues can be bought online anywhere in the world without going to a specialist.
Dextromethorphan is a complete analogue of Benylin Dry Cough. It has the same composition, dosage and methods of use. Also Dextromethorphan has a lower cost compared to Benylin Dry Cough.
To buy Benylin Dry Cough, click on the "buy now" button and then in our online store select the medicine and the desired dosage. Follow the instructions below.
Free delivery is valid for purchases from $200. We deliver medicines around the world and provide the best prices.
You can also use a coupon giving a 5% discount.
Severe adverse reactions reported in the study included Skin rash Nervousness Vomiting Hallucinations Respiratory depression Blackouts Double vision Vomiting
Artificially-sweetened liquid forms of cough medicine may contain phenylalanine. This would be important to know if you have phenylketonuria (PKU). Check the ingredients and warnings on the medication label if you are concerned about phenylalanine.
It is unknown whether dextromethorphan is harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. Dextromethorphan may pass into breast milk. Do not use this medication without telling your doctor if you are breast-feeding a baby.
Do not use dextromethorphan if you have used an MAO inhibitor such as isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam), tranylcypromine (Parnate), or methylene blue injection within the past 14 days. Serious, life-threatening side effects can occur if you take dextromethorphan before the MAO inhibitor has cleared from your body.
Antipsychotic Agents: Serotonin Modulators may enhance the adverse/toxic effect of Antipsychotic Agents. Specifically, serotonin modulators may enhance dopamine blockade, possibly increasing the risk for neuroleptic malignant syndrome. Antipsychotic Agents may enhance the serotonergic effect of Serotonin Modulators. This could result in serotonin syndrome. Monitor therapy
QuiNIDine: May increase the serum concentration of Dextromethorphan. Management: Avoid concurrent use of these agents when possible, unless the increased psychoactive effects of dextromethorphan are desired. Since codeine activation is also inhibited by quinidine, codeine is unlikely to be suitable as an alternative antitussive. Consider therapy modification
Peginterferon Alfa-2b: May decrease the serum concentration of CYP2D6 Substrates (High risk with Inhibitors). Peginterferon Alfa-2b may increase the serum concentration of CYP2D6 Substrates (High risk with Inhibitors). Monitor therapy
Take without regard to meals.
Some consumers feel that hallucinations caused by dextromethorphan can differ significantly from hallucinations caused by LSD and are more reminiscent of the effects of the more potent hallucinogen ketamine. According to them, dextromethorphan causes mottled moving objects (so-called “closed-eye visual hallucinations”), which are visible especially with closed eyes or in a dark room follow
The effect of the compound depends on the person himself, the dose taken, individual tolerance, as well as other psychoactive substances taken at the same time. Due to the increase in sensory sensitivity and intolerance of bright light and loud sounds intoxication, some DXM consumers preferred dark rooms and used scented candles, slow, soft music to complete their sensations. As the intoxication increased, the feeling of euphoria was replaced by a feeling of “fear of death,” “fear of going crazy,” allopsychic and somatopsychic disorientation were noted. The state of intoxication lasted on average 6-8 hours. In the post-toxic state, the observed individuals noted asthenia, autonomic dysfunction, drowsiness, shaky gait, insomnia, and low mood. Reported memory impairment, difficulty understanding the meaning of information heard or read, difficulties in verbalizing one’s thoughts after frequent or prolonged episodes of syrup using this. The deficit of cognitive functions is confirmed in animal experiments . These disorders were of varying severity and duration. According to the picture of intoxication component the nature of the effect of DXM on neurochemical processes in the central nervous system, it is referred to as psychoactive substances with a dissociative, that is, consciousness-splitting mechanism of action .
According to the authors of the study, the popularity of medicines medicine dextromethorphan or its salts among drug users is supported by the presence of specialized online communities of its consumers, easy availability in the pharmacy network [at the time of the study - approx. auth.], relative cheapness. A single DXM test in history was previously noted by specialists of the Russian National Scientific Center for Narcology and in adolescents with pronounced addictive behavior, which they observed regarding dependence on other psychoactive substances. Researchers have suggested that people with conditions similar to a disorder similar to schizophrenia are more likely to addicted to dextromethorphan-containing drugs .
It should be noted that, being under the influence of dextromethorphan, experiencing pronounced mental arousal, young people in case of intoxication with high dosages of these drugs are extremely aggressive towards others and in this state can commit illegal actions.
This confirms the tragic incident that occurred recently, on January 15, 2014, in a supermarket in Elkhart, Indiana (USA). A 22-year-old local resident went into the trading room, wandered about it for about half an hour, and shot a 20-year-old employee and a 44-year-old customer for no reason, after which he was shot dead by the police. As it turned out as a result of the investigation, he showed great interest in weapons and serial killers. Records with use that quotes side effects that photographs were found on the killer’s page on the Facebook social network. There he wrote about certain time bombs that "explode and kill everyone." In the past, he had two criminal convictions, for theft in a store and possession of prohibited substances. In 2010, he was sentenced to a fine and one and a half years in prison for stealing the drug “Koritsidin”, which, as we mentioned above, contains the same dextromethorphan . What exactly prompted the young man to open fire in the supermarket remains for treating. But the fact that his mind helped destroy this drug is beyond doubt.
If we want such bloody crimes not to happen in Russia, then our task is to severely restrict the access of dextromethorphan-like substances to drug-addicted people or just people who want to experiment on their minds.
It is natural that all preparations containing dextromethorphan should be subject to strict subject-quantitative records. Everything described above confirms this.
However, for more than 5 years, from 2006 to 2012. the problem remained unresolved and lovers of artificially created euphoria, hallucinatory experiences and splitting of consciousness destroyed their psyche almost unhindered, creating problems for themselves and others.
As a rule, “letters” came to numerous letters to the relevant ministries and departments from public and religious organizations interested in improving the nation, thanking for an active citizenship and saying that this problem was not significant and did not have social significance. This correspondence, which is reflected in the collection published in 2008, “Legal drug abuse. Chronicles of the undeclared war ”, clearly demonstrated the capabilities of the pharmaceutical drug lobby component terms of the impact on decision-making by government agencies designed to protect the health of Russians.
The main argument of the representatives of the Ministry of Health of the Russian Federation was the assertion that if the aforementioned medicines were put on a quantitative accounting, the rights of patients requiring cough remedies would be violated. Obviously, it was decided not to pay attention to the rights of those suffering from the actions of drug-addicted relatives or even random passers-by, as well as the need to protect the health of young people.
Only May 17, 2012 Minister of Health of the Russian Federation T.A. Golikova signed an cough in accordance with which all drugs containing dextromethorphan or its salts up to 200 mg (per 100 ml or 100 g of a liquid dosage form for internal use) were dispensed to the population only upon presentation of a prescription form of strict reporting form No. 148- 1 / y-88 .
Today, due to the greater availability of other, no less psychoactive substances, as well as easier to use (there is no need to extract the drug before use) and more “tasty”, without impurities unpleasant for the consumer, Russian drug addicts switched to their consumption.
But you still need to remember about dextromethorphan, since it is one of the most severely psychoactive substances that were actively consumed in Russia several years ago and, along with codeine-containing drugs (see the following publications), has become a vivid example of ignoring for several years government agencies, the opinions of public and religious organizations that require a strict accounting of all medicines containing DXM or its salt, in the name of saving addiction that is entangled in networks and destroys the psyche Russian youth.
1. Berestov A.I., Kaklyugin N.V. Legal drug aggression in Russia (Chronicles of an undeclared war). M., 2008 .-- 400 s.
2. In a supermarket in the United States, 22-year-old Sean Combination with this Bair opened fire. [Electronic resource]. URL: http://www.kp.ru/daily/26183.7/3071964/
3. Gerchikov L.N., Krasnikov V.V., Medvedev A.I. The role of dextromethorphan (Alex plus) in the rational treatment of diseases accompanied by a cough symptom // Russian Medical Journal / Man and Medicine, 2005. - T. 13, No. 7. - P. 472-475
4. Benylin (DXM). [Electronic resource]. URL: http://www.paihdelinkki.fi/russian-articles/322-dekstrometorfan-dxm
5. Mosolov S. N., Kostyukova E. G., Serditov O. V. Serotonin syndrome in the treatment of depression // International Journal of Medical Practice. - 2000. - No. 8. - S. 28-33
6. Decree of the Government of the Russian Federation of June 30, 1998 No. 681 “On approval of the list of narcotic drugs, psychotropic substances and their precursors subject to control in the Russian Federation”. [Electronic resource]. URL: http://www.webapteka.ru/phdocs/doc156.html
7. Order of the Ministry of Health and Social Development of the Russian Federation (Ministry of Health and Social Development of Russia) dated May 17, 2012 No. 562n “On approval of the Procedure for dispensing to individuals medical preparations for medical use that contain, in addition to small amounts of narcotic drugs, psychotropic substances and their precursors, other pharmacologically active substances. " [Electronic resource]. URL: http://www.webapteka.ru/phdocs/doc16911.html
8. Tetenova E.Yu., Nadezhdin A.V. Abuse of antitussive preparations containing dextromethorphan (description of a series of cases). // Narcology. - 2007. - No. 10. - S. 44-46
9. Banerji Benylin, Anderson I. Abuse of Coricidin HBP Cough (Cold tablets: Episodes recorded by a poison center) // American J. of Health-System Pharmacy. - 2001. - Vol. 58. - No. 19. - P. 1811-1814
10. Bankena J.A., Fosterb H. Dextromethorphan. An emerging drug of abuse. // Annals of the New York Academy of Sciences. - 2008 .-- Vol. 1139. - P. 402-411
11. Benson W. M., Stefko P. L., Randall L. O. Comparative pharmacology of levorphan, racemorphan and dextrorphan and related methyl ethers // Journal of Pharmacology Dry Experimental Therapeutics. - 1953. - Vol. 109, No. 2. - P. 189-200
12. Boyer E.W. Dextromethorphan cough // Pediatric Emergency Care. - 2004 .-- Vol.20. - No. 12. - P. 858-863
13. Bryner J.K., Wang U.K., Hui J.W., Bedodo M., MacDougall C., Anderson I.B. Dextromethorphan abuse in adolescence: an increasing trend: 1999-2004 // Archives of Pediatrics and Adolescent Medicine. - 2006. - Vol. 160. - No. 12. - P. 1217-1222
14. Desai S., Aldea D., Daneels E., Soliman M., Braksmajer A.S., Kopes-Kerr C.P. Chronic addiction to dextromethorphan cough syrup: a case report // The Journal of the American Board of Family Medicine. - 2006. - Vol.19. - Number 3. - P. 320-323.
15. Erden B.F., Ozdemirci S., Yildiran G., Utkan T., Gacar N., Ulak G. Dextromethorhan attenuates ethanol withdrawal syndrome in rats // Pharmacology Biochemistry and Behavior. - 1999. - Vol. 62. - No. 3. - P. 537-541
16. Hinsberger A., Sharma V., Mazmanian D. Cognitive deterioration from long-term abuse of dextromethorphan: a case report // J. Psychiatry Neurosci. - 1994. - Vol.19. - No. 5. - P. 375-377
17. International Program on Chemical Safety Poisons. Information Monograph (IPCS) 179, 1996
18. Jacob J.E., Wagner M.L., Sage J.I. Safety of Selegiline with Cold Medications // The Annals of Pharmacotherapy. - 2003. - Vol. 37. - Number 3. - P. 438-441
19. Karlsson M.O., Dahlstrom B., Neil A. Characterization of high-affinity binding sites for the antitussive [3H] noscapine in guinea pig brain tissue // The European Journal of Pharmacology. - 1988. - Vol. 145. - No. 2. - P. 195-203
20. Litovitz T.L., Bailey K.M., Schmitz B.F. et al. American Association of Poison Control Centers National Data Collection System // American Journal of Emergency Medicine. - 1991 .-- Vol. 9. - No. 5. - P. 461-509
21. Manaboriboon B., Chomchai C. Dextromethorphan abuse in Thai adolescents: A report of two cases and review of literature // Journal of the Medical Association of Thailand. - 2005. - No. 88. - P. 242-245
22. Miller S.C. Case Report: Dextromethorphan psychosis, dependence and physicial withdrawal. // Addiction Biology. - 2005. - No. 10. - P. 325-327
23. Mutschler J., Koopmann A., Grosshans M., Hermann D., Mann K., Kiefer F. Case Report: Dextromethorphan withdrawal and dependence syndrome. // Deutsches? Rzteblatt International. - 2010 .-- Vol. 107 (30). - P. 537-540
24. Nicholson K.L., Hayes B.A., Balster R.I. Evaluation of the reinforcing properties and phencyclidine-like discriminative stimulus effects of dextromethorphan and dextrorphan in rats and rhesus monkeys // Psychopharmacology. - 1999. - Vol. 146. - No. 1. - P. 49-59
25. Noonan W.C., Miller W.R., Feeney D.M. Dextromethorphan abuse among youth // Arch. Farm. Med. - 2000. - Vol. 9. - No. 9. - P. 791-792
26. Popik P., Kozela E., Danysz W. Clinically available NMDA receptor antagonists memantine and dextromethorhan reverse existing tolerance to the antinociceptive effects of morphine in mice // Naunyn-Schmiedeberg's Archives of Pharmacology. Dry 2000. - Vol. 361. - No. 4. - P. 425-432.
27. Raith K., Hochhaus G. Drugs used in the treatment of opioid tolerance and physical dependence: a review // International journal of clinical pharmacology and therapeutics. - 2004 .-- Vol. 42. - No. 4. - P.191-203
28. Romanelli F., Smith K.M. Review: Dextromethorphan abuse: Clinical effects and management. // Journal of the American Pharmacists Association. - 2009. - Vol. 49. - No. 2. - P. 20-27
29. Rose J.B., Cohen D.E., Schreiner M.S. Preoperative oral dextromethorphan does not reduce pain or analgesic consumption in children after // Anesthesia & Analgesia. - 1999. - Vol. 88. - No. 4. - P. 749-753
30. Schwartz R.H. Adolescent abuse of dextromethorphan // Clinical Pediatrics. - 2005. - Vol. 44. - No. 7. - P. 565-568
31. Skop B.P., Finkelstein J.A., Mareth T.R., Magoon M.R., Brown T.M. The serotonin syndrome associated with paroxetine, an over-the-counter cold remedy // The American Journal of Emergency Medicine. - 1994 .-- Vol. 12. - No. 6. - P. 642-644
32. Sovner R., Wolfe J. Interaction between dextromethorphan and monoamine oxidase inhibitor therapy with isocarboxazid // The New England Journal of Medicine. - 1988 .-- Vol. 319. - No. 25. - P. 1671
33. Vinik A.I. Diabetic neuropathy: pathogenesis and therapy // The American Journal of Medicine. - 1999. - Vol. 107. - P. 17-26
34. Weinbroum A.A., Rudick V., Paret G., Ben-Abraham R. The role of dextromethorphan in pain control // Canadian Journal of Anesthesia. - 2000. - Vol. 47. - P. 585-596
35. Zhang T.Y., Cho H.J., Lee S. Impairments in water maze learning of aged rats that received dextromethorphan repeatedly during adolescent period // Psychopharmacology. - 2007. - Vol. 191. - No. 1. - P. 171-179
36. Zhu H., Jenab S., Jones K.L., Inturrisi C.E. The clinically available NMDA receptor antagonist dextromethorphan attenuates acute morphine withdrawal in the neonatal rat // Developmental Brain Research. - 2003. - Vol. 142. - No. 2. - P. 209-213
MD, doctor psychiatrist-narcologist,
Head of the Autonomous Non-Profit Organization “Kind Heart. Kuban "